Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Comparative metabolomics revealed key pathways associated with the synergistic killing of multidrug-resistant Klebsiella pneumoniae by a bacteriophage-polymyxin combination. Local targets link to admitted publications; unresolved targets remain external evidence.
The changing face of Klebsiella pneumoniae infections in the community
10.1016/j.ijantimicag.2007.06.019 · 2007 · External reference
Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance
10.1128/aac.01019-15 · 2015 · External reference
10.1128/cmr.00181-19
10.1128/cmr.00181-19 · External reference
10.1021/acsinfecdis.5b00085 · 2015 · Admitted local publication
10.1093/jac/dkv135
10.1093/jac/dkv135 · External reference
Colistin resistance in Klebsiella pneumoniae
10.1016/j.ijantimicag.2014.02.016 · 2014 · External reference
Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin
10.1128/aac.00084-14 · 2014 · External reference
Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection
10.1128/jcm.02466-08 · 2009 · External reference
10.1016/j.chom.2019.01.014
10.1016/j.chom.2019.01.014 · External reference
10.4292/wjgpt.v8.i3.162
10.4292/wjgpt.v8.i3.162 · External reference
Phage therapy regulation: from night to dawn
10.3390/v11040352 · 2019 · External reference
Bacteriophage therapy: a regulatory perspective
10.1093/jac/dkw083 · 2016 · External reference
10.4161/bact.1.2.14590
10.4161/bact.1.2.14590 · External reference
Phage therapy—advantages over antibiotics?
10.1016/s0140-6736(05)74059-9 · 2000 · External reference
Fighting pathogenic bacteria on two fronts: phages and antibiotics as combined strategy
10.3389/fcimb.2019.00022 · 2019 · External reference
Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro
10.1111/j.1574-695x.2012.00977.x · 2012 · External reference
Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa
10.1016/j.resmic.2012.08.008 · 2013 · External reference
10.1111/j.1752-4571.2011.00236.x
10.1111/j.1752-4571.2011.00236.x · External reference
Synergistic interaction between phage therapy and antibiotics clears Pseudomonas aeruginosa infection in endocarditis and reduces virulence
2017 · External reference
10.3390/v6103778
10.3390/v6103778 · External reference
10.1038/ismej.2013.216
10.1038/ismej.2013.216 · External reference
Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B5055
10.1007/s11274-009-9991-8 · 2009 · External reference
Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice
10.1099/jmm.0.2008/002873-0 · 2008 · External reference
10.3390/antibiotics8040182
10.3390/antibiotics8040182 · External reference
Rescuing the last-line polymyxins: achievements and challenges
10.1124/pharmrev.120.000020 · 2021 · External reference
10.1038/s41579-019-0270-x
10.1038/s41579-019-0270-x · External reference
10.1093/jac/dkz314
10.1093/jac/dkz314 · External reference
Unresolved reference
External reference
10.7717/peerj.2261
10.7717/peerj.2261 · External reference
Bacteriophage enumeration and detection methods
2020 · External reference
Evaluation of agar dilution and broth microdilution methods to determine the disinfectant susceptibility
10.1038/ja.2015.51 · 2015 · External reference
Comparative metabolomics and transcriptomics reveal multiple pathways associated with polymyxin killing in Pseudomonas aeruginosa
2019 · External reference
10.1093/bioinformatics/bts069
10.1093/bioinformatics/bts069 · External reference
10.1021/ac051437y
10.1021/ac051437y · External reference
10.1021/ac2000994
10.1021/ac2000994 · External reference
10.1007/s11306-012-0434-4
10.1007/s11306-012-0434-4 · External reference
10.1093/nar/gky310
10.1093/nar/gky310 · External reference
How does multiple testing correction work?
10.1038/nbt1209-1135 · 2009 · External reference
10.1111/bph.13895
10.1111/bph.13895 · External reference
10.1016/j.idc.2016.02.005
10.1016/j.idc.2016.02.005 · External reference
Invertible DNA determines host specificity of bacteriophage Mu
10.1038/286218a0 · 1980 · External reference
10.1038/s41564-019-0477-7
10.1038/s41564-019-0477-7 · External reference
In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
10.1093/jac/dkn425 · 2008 · External reference
10.1111/1574-6976.12006
10.1111/1574-6976.12006 · External reference
Pharmacology of polymyxins: new insights into an ‘old’ class of antibiotics
10.2217/fmb.13.39 · 2013 · External reference
10.1186/1471-2180-11-258
10.1186/1471-2180-11-258 · External reference
10.1128/jb.02267-12
10.1128/jb.02267-12 · External reference
10.1038/nrmicro2351
10.1038/nrmicro2351 · External reference
10.1016/j.molcel.2010.08.031
10.1016/j.molcel.2010.08.031 · External reference
Phage therapy in the postantibiotic era
2019 · External reference
Next-generation “-omics” approaches reveal a massive alteration of host RNA metabolism during bacteriophage infection of Pseudomonas aeruginosa
10.1371/journal.pgen.1006134 · 2016 · External reference
10.1128/mr.45.4.620-642.1981
10.1128/mr.45.4.620-642.1981 · External reference
10.1038/ismej.2016.3
10.1038/ismej.2016.3 · External reference
10.1038/nrmicro2315
10.1038/nrmicro2315 · External reference
10.1021/jm900999h
10.1021/jm900999h · External reference
Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumannii
2017 · External reference
